Successful Treatment of Skin Dyskeratosis Due To NLRP1 Mutation Using Baricitinib

J Clin Immunol. 2025 Jul 5;45(1):110. doi: 10.1007/s10875-025-01909-8.

NO ABSTRACT

PMID:40616725 | DOI:10.1007/s10875-025-01909-8